• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC MEXICO S. DE R.L. DE CV AXIUM PRIME BRPL HLX; DEVICE, VASCULAR, FOR PROMOTING EMBOLIZATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC MEXICO S. DE R.L. DE CV AXIUM PRIME BRPL HLX; DEVICE, VASCULAR, FOR PROMOTING EMBOLIZATION Back to Search Results
Model Number APB-1-2-HX-ES
Medical Device Problem Code Break (1069)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 12/23/2024
Type of Reportable Event Malfunction
Event or Problem Description
Medtronic received information regarding an axium coil that was broken at the detachment point.The patient was undergoing a coil embolization procedure to treat an unruptured saccular aneurysm located at the c7 posterior communicating artery (pcom) segment.The aneurysm had a max diameter of 2.5mm and a neck diameter of 2mm.Patient's blood flow was normal.Patient's vessel tortuosity was minimal.It was reported that the axium coil and all accessory devices were prepared as indicated in the instruction for use (ifu).A 1.5-3 coil was delivered and deployed successfully as the first coil in the procedure.An axium coil (apb-1-2-hx-es) was then selected.However, when the protective sheath was removed, it was observed that the detachment point of coil was broken so the coil was not used.It was replaced with another coil of the same model which was successfully placed.No significant contrast agent retention observed in the aneurysm.The procedure was completed without any patient symptoms or complications.
 
Additional Manufacturer Narrative
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Event or Problem Description
Additional information was received that there were no detachment attempts.There was no kink/damage observed on the pushwire.It was reported that after the coil was removed and standard hydration was performed, the coil was found to be abnormal in shape under the dsa machine when preparing for embolization.The coil was then pushed out for observation and the detachment point was found to be broken.Considering the surgical risk, the coil was replaced.
 
Additional Manufacturer Narrative
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Additional Manufacturer Narrative
Product analysis # (b)(4): equipment used: vis (m-78210), 203cm ruler (m-83361) as found condition (condition of returned device): an axium prime coil was returned for analysis within a shipping box; within sealed biohazard pouch and within a dispenser track.The axium prime coil was returned within introducer sheath.Visual inspection/damage location details: the actuator interface was securely attached to the coupler tube.No evidence of mechanical detachment using an instant detacher was found at this location.The pushwire was found to be broken but retained by release wire at break indicator.The coin was found still against the lumen stop.The shield coil was found intact.The implant coil appeared to be still attached, stretched and damaged within introducer sheath.The implant coil was pushed out of introducer sheath for additional analysis.The implant coil was found to be stretched and damaged.No other anomalies were observed.Testing/analysis (including sem reports): n/a conclusion: based on the analysis performed, the customers report of ¿coil separation/break¿ was unable to be confirmed as the pushwire was returned with the implant coil still attached.The root cause could not be determined.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AXIUM PRIME BRPL HLX
Common Device Name
DEVICE, VASCULAR, FOR PROMOTING EMBOLIZATION
Manufacturer (Section D)
MEDTRONIC MEXICO S. DE R.L. DE CV
av. paseo del cucapah #10510
tijuana,bc 22210
MX  22210
Manufacturer (Section G)
MEDTRONIC MEXICO S. DE R.L. DE CV
av. paseo del cucapah #10510
tijuana,bc 22210
MX   22210
Manufacturer Contact
justin ellis
9775 toledo way
irvine, CA 92618
7635265677
MDR Report Key21072967
Report Number9617601-2025-00025
Device Sequence Number8386442
Product Code KRD
UDI-Device Identifier00763000313791
UDI-Public00763000313791
Combination Product (Y/N)N
Initial Reporter CountryCH
PMA/510(K) Number
K151447
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date (Section B) 03/13/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model NumberAPB-1-2-HX-ES
Device Catalogue NumberAPB-1-2-HX-ES
Device Lot Number228012937
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 12/23/2024
Supplement Date Received by Manufacturer01/10/2025
02/24/2025
Initial Report FDA Received Date01/03/2025
Supplement Report FDA Received Date01/31/2025
03/13/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured01/03/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient Age67 YR
Patient SexFemale
-
-